While HR scrambles to find the budget to cover these drugs, PBMs use spread pricing and rebate retention to extract massive margins off the new volume
And when it comes to health, I do not want to scrimp
The American Diabetes Associations Standards of Medical Care in Diabetes2020 recommend that use of SGLT2s and GLP-1s be considered in patients with or at high risk for cardiovascular disease, kidney disease, or heart failure regardless of patients current A1c or A1c target
Project administration: Fahad S
More precisely, in early clinical trials, Retatrutide has shown the potential for significant weight loss, with participants on the highest dose losing an average of 28.7% of their body weight over 68 weeks, which is double the weight loss seen with other GLP-1 medications like Ozempic and Wegovy
After your first month of treatment, you can add the Precision Peptide Genetic Test for $99 to reveal how your genes influence semaglutide response and optimize your personalized protocol